Beam Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.28 billion, with shareholders equity totaling $952.67 million.
The company employs approximately 557 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Beam Therapeutics Inc. reported $146.64 million in revenue, generating net income of $-108.20 million.
Key financial metrics include a P/E ratio of -21.05, a price-to-book (P/B) ratio of 2.39, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BEAM.